The 12-month price targets, analyzed by analysts, offer insights with an average target of $508.38, a high estimate of ...

The stock's fall snapped a four-day winning streak.

Today's Research Daily features new research reports on 16 major stocks, including NVIDIA Corporation (NVDA), The Home Depot, Inc. (HD) and Vertex Pharmaceuticals Incorporated (VRTX), as well as a ...

A team from SSPC, the Research Ireland Centre for Pharmaceuticals, wants to look at the impact gravity has on small molecules both in space and on Earth, which could boost both material and ...

Jazz Pharmaceuticals' diversified drug portfolio drives revenue growth, but mixed clinical results ... mostly linked to a moderate increase in the research & development costs, derived from ...

Amphastar Pharmaceuticals shows promising growth potential with its diverse product offerings, including the nasally administered glucagon treatment BAQSIMI and the over-the-counter inhalant ...

Needham analyst Joseph Stringer maintained a Buy rating on Phathom Pharmaceuticals (PHAT – Research Report) today and set a price target of $26.00. Joseph Stringer has given his Buy rating due ...

Alnylam Pharmaceuticals, Inc. operates as biopharmaceutical company, which engages in the discovery, development and commercialization of RNAi therapeutics. It is the translation of RNAi as a new ...

Name Insider Ownership Earnings Growth Hartshead Resources (ASX:HHR) 13.9% 102.6% Clinuvel Pharmaceuticals (ASX:CUV) 13.6% 26.5% ...

So our pharmaceutical is effectively a drone ... But that means we have an infrastructure problem. Where to do the research and to conduct the clinical trials and treat patients.

These are complementary indicators that rate stocks based on value, growth ... Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report BioMarin ...